Glaucoma | Glaucoma Symptoms | Visual Field Test

Mar 27, 2009 16:16 ET

Dr. Robert Maloney, World Renowned Eye Doctor, Joins the VisionRx Advisory Board

GREENWICH, CT--(Marketwire - March 27, 2009) - Robert Maloney, M.D., a Rhodes Scholar and Summa Cum Laude graduate of Harvard, completed his education at Oxford University and Johns Hopkins Hospital. Dr. Maloney was the first surgeon in western North America to perform LASIK surgery during the original FDA clinical trials. He is Professor of Ophthalmology, UCLA, and Director, Maloney Vision Institute, in Los Angeles. Voted by his peers as one of America's top ten vision-correction specialists in a nationwide survey by Ophthalmology Times, Dr. Maloney has trained over 700 surgeons in excimer laser surgery and personally performed more than 45,000 vision-correction surgeries. He has a special clinic for patients with problems from prior vision correction surgery.

He has received the International Society of Refractive Surgeons' prestigious Lans Award, for his innovations in vision-correction surgery, and the American Academy of Ophthalmology's Senior Honor Award for contributions to the education of other eye surgeons, and the Secretariat Award for distinguished contributions to the Academy. He has published more than 100 articles and reports in professional journals and delivered more than 200 invited lectures on five continents. Dr. Maloney has been principal investigator for fourteen FDA clinical trials.

Dr. Maloney has appeared frequently as the exclusive LASIK surgeon for the ABC television series "Extreme Makeover." He has been interviewed by the Discovery Channel, the Learning Channel, NBC's "Extra," ABC's "20/20" and "Primetime Live," PBS's "Life & Times," and CNN's "Your World Today." He has also been featured in numerous magazines and newspapers.

As a VisionRx Advisory Board member, Dr. Maloney will provide guidance on medical issues. VisionRx is a professional vision test software company that provides online glaucoma tests for everyone. VisionRx is dedicated to raising awareness, improving detection, and the eventual elimination of glaucoma and other eye diseases. For more information about VisionRx and GlaucomaCheck™ visit www.visionrx.com.

Glaucoma is one of the two leading causes of blindness. Over half of those affected do not know they have the disease because early glaucoma symptoms can only be detected using specialized tests. Damage to the retina caused by the disease is permanent. However, once the symptoms of glaucoma are diagnosed it can be treated and progression stopped. Early diagnosis is crucial to prevent irreversible vision loss. While anyone can get the disease, major risk factors include: age, family history of glaucoma, significant nearsightedness and diabetes.

Feb 05, 2009 13:28 ET

Dr. Robert Maloney Says VisionRx GlaucomaCheck™ Is an Important Step Forward in Early Glaucoma Detection

GREENWICH, CT--(Marketwire - February 5, 2009) - Dr. Robert Maloney, of Maloney Vision Institute, Los Angeles, CA, a world renowned ophthalmologist seen on Extreme Makeover, says:

"VisionRx's GlaucomaCheck™ is an important step forward in the early detection of glaucoma and prevention of blindness. It is what eyecare professionals refer to as a visual field test. Of all of the instruments and techniques that eye doctors use to diagnose glaucoma, the visual field analyzer is one of the most important. This instrument gives a measure of the functioning of the retina whose cells are killed by this blinding disease.

"GlaucomaCheck™ can allow the user to find evidence of glaucoma at an early stage, before vision is permanently impaired. By allowing people to test their eyes anytime and anywhere, it provides a convenient, easy to use, and economical method which is accessible to everyone.

"I highly recommend that everyone have regular eye exams, especially those who are over 40 years of age or have a family history of glaucoma. GlaucomaCheck™ is a great way to have an early indication of a problem with this silent blinding disease."

Glaucoma is one of the two leading causes of blindness. Over half of those people affected do not know that they have the disease because early glaucoma symptoms can only be detected using specialized tests. Damage to the retina caused by the disease is permanent and irreversible. However, once diagnosed glaucoma can be treated and its progression stopped. Early diagnosis is crucial to prevent irreversible vision loss. While anyone can get the disease, major glaucoma risk factors include: age, family history of glaucoma, significant nearsightedness and diabetes.

VisionRx is a professional vision test software company that provides glaucoma tests for everyone. VisionRx is dedicated to helping raise awareness, improving detection, and the eventual elimination of glaucoma and other eye diseases. For more information about VisionRx and GlaucomaCheck™ visit www.visionrx.com.

Jan 16, 2009 16:34 ET

VisionRx GlaucomaCheck™ is the First Patented, Clinical-Grade Online Glaucoma Test

GREENWICH, CT--(Marketwire - January 16, 2009) - In support of National Glaucoma Awareness Month, VisionRx has launched its groundbreaking online glaucoma test, known as GlaucomaCheck™. Now anyone can screen for glaucoma in the convenience of their own home. Glaucoma is one of the two leading causes of blindness. Over half of those people affected do not know that they have the disease because early glaucoma symptoms can only be detected using specialized tests. Damage to the retina caused by the disease is permanent and irreversible. However, once diagnosed glaucoma can be treated and stopped. Early diagnosis is crucial to prevent irreversible vision loss. While anyone can get the disease, major glaucoma risk factors include: age over 45, family history of glaucoma, significant nearsightedness and diabetes.

GlaucomaCheck™ is what eyecare professionals refer to as a visual field test. It is the first and only patented online glaucoma test accurate and sensitive enough to be used by doctors. First provided online in 1999, GlaucomaCheck™ was, in fact, originally designed for eye doctors. It is inexpensive, fast (less than one minute per eye) and easy to use. It provides immediate results with AutoAnalysis™. GlaucomaCheck™ helps detect glaucoma early – before the damage is done.